FIELD: medicine. SUBSTANCE: it is described application of inhibitors of gastro-intestinal lipase to prepare medicinal preparations prescribed orally either for treating or preventing type II diabetes due to decreasing Alc-hemoglobin levels. The suggested preparation enables to decrease dosage or stop application of hypoglycemic preparations in patients with type II diabetes. EFFECT: higher efficiency of application. 1 cl, 4 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| PHARMACEUTICAL COMPOUND | 1994 |
|
RU2141844C1 |
| PHARMACEUTICAL COMPOSITION CONTAINING LIPASE INHIBITOR AND GLUCOMANNAN | 2003 |
|
RU2297221C2 |
| TETRAHYDROLIPSTATIN-CONTAINING COMPOSITIONS | 1998 |
|
RU2170579C2 |
| NOVEL PHARMACEUTICAL COMPOSITION | 2001 |
|
RU2241462C2 |
| DIBENZOSUBERONE DERIVATIVES | 2005 |
|
RU2391337C2 |
| SOLID LIPID COMPOSITIONS | 2000 |
|
RU2248218C2 |
| DISPERSION COMPOSITION CONTAINING LIPASE INHIBITORS | 2000 |
|
RU2239428C2 |
| NOVEL SPIROPENTACYCLIC COMPOUNDS | 2005 |
|
RU2360909C2 |
| DERIVATIVES OF OXAZOLE AND THEIR USING AS INSULIN SENSITIZING AGENTS, PHARMACEUTICAL COMPOSITION POSSESSING ACTIVATING EFFECT ON PPARα AND/OR PPARγ | 2003 |
|
RU2295520C2 |
| DERIVATIVES OF 1,1-DIOXOTHIOMORPHOLINYLINDOLYL METHANONE FOR USE AS HISTAMINASE MODULATORS | 2006 |
|
RU2412182C2 |
